Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841252 · ClinicalTrials.gov registry record
Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 266
- Enrollment target
NCT04841252: Completed study, sponsored by Mayo Clinic.
NCT04841252 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 266 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04841252 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 266 participants
- Enrollment target
Study Summary
The purpose of this research is to conduct a clinical study to evaluate the efficacy of a noninvasive and quantitative tool for classification/diagnosis of breast masses. The main objective of this proposal is to test the SAVE (Sub-Hertz Analysis of Visco-Elasticity) method on a patient population of sufficient size to determine the sensitivity and specificity for malignant-benign discrimination of breast masses.
Interventions
- DEVICE FDA approved GE LOGIQ E9 (LE9) ultrasound
- DEVICE Alpinion clinical ultrasound machine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2012-12-19 |
| Est. Completion | 2024-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841252
The ClinicalTrials.gov registry entry for NCT04841252 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FDA approved GE LOGIQ E9 (LE9) ultrasound is the first listed.
NCT04841252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04841252 about?
NCT04841252 is a clinical study titled "Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method". The purpose of this research is to conduct a clinical study to evaluate the efficacy of a noninvasive and quantitative tool for classification/diagnosis of breast masses. The main objective of this proposal is to test the SAVE (Sub-Hertz Analysis of Visco-Elasticity) method on a patient population o...
What is the current status of trial NCT04841252?
This trial is currently completed. The enrollment target is 266 participants. The study started on 2012-12-19. Estimated completion is 2024-06-25.
What interventions are being tested in trial NCT04841252?
The interventions under investigation include: FDA approved GE LOGIQ E9 (LE9) ultrasound (DEVICE), Alpinion clinical ultrasound machine (DEVICE).
Who is sponsoring clinical trial NCT04841252?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.